| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |